Cargando…

Hematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease: Should It Be Considered?

Hematopoietic stem cell transplantation (HSCT) is widely used in benign and malignant hematological diseases. During the last decade, HSCT, mainly autologous, also gained increasing attention in the treatment of refractory autoimmune diseases. Crohn’s disease (CD) is an inflammatory bowel disease le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reider, Simon, Binder, Lukas, Fürst, Stefan, Hatzl, Stefan, Blesl, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656531/ https://www.ncbi.nlm.nih.gov/pubmed/36359859 http://dx.doi.org/10.3390/cells11213463

Ejemplares similares

Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015)

Is it time to use hematopoietic stem cell transplantation for severe and refractory crohn's disease?
por: Ruiz, Milton Artur, et al.
Publicado: (2020)

What should we consider in mixed chimerism after hematopoietic stem cell transplantation?
por: Lim, Jihyang
Publicado: (2011)

Hematopoietic stem cell transplantation in a severe refractory Crohn’s disease patient with intestinal stoma: a case report
por: Ruiz, Milton Artur, et al.
Publicado: (2017)

Hematopoietic stem cell transplantation for Crohn’s disease: Gaps, doubts and perspectives
por: Ruiz, Milton Artur, et al.
Publicado: (2018)

Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017)

Medical, ethical, and legal aspects of hematopoietic stem cell transplantation for Crohn’s disease in Brazil
por: Ruiz, Milton Artur, et al.
Publicado: (2020)

TRANSPLANTATION OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN REFRACTORY CROHN’S DISEASE: SYSTEMATIC REVIEW
por: BERNARDI, Luana, et al.
Publicado: (2019)

Who Should Be Considered for Islet Transplantation Alone?
por: Othonos, Nantia, et al.
Publicado: (2017)

Efficacy and safety of autologous hematopoietic stem cell therapy for refractory Crohn's disease: A systematic review and meta-analysis
por: Qiu, Xiao, et al.
Publicado: (2017)

Role of Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma
por: Carella, Angelo Michele
Publicado: (2012)

Allogeneic hematopoietic stem cell transplantation for Crohn disease complicated with myelodysplastic syndrome: A case report
por: Zhang, Ying, et al.
Publicado: (2020)

Is there a role for allogeneic hematopoietic stem cell transplantation for refractory follicular lymphoma?
por: Yang, Yang, et al.
Publicado: (2022)

Immunosuppression in Renal Transplantation and Dyslipidemia, Which Factors Should Be Considered?
por: De Giorgi, Alfredo, et al.
Publicado: (2013)

Should the meniscal height be considered for preoperative sizing in meniscal transplantation?
por: Netto, Alfredo dos Santos, et al.
Publicado: (2017)

Effects of Posaconazole on Tacrolimus Population Pharmacokinetics and Initial Dose in Children With Crohn’s Disease Undergoing Hematopoietic Stem Cell Transplantation
por: Chen, Xiao, et al.
Publicado: (2022)

Salvaged allogeneic hematopoietic stem cell transplantation for pediatric chemotherapy refractory acute leukemia
por: Wang, Jingbo, et al.
Publicado: (2017)

Should We Consider Cancers as Embryonic Diseases or as Consequences of Stem-Cell Deregulation?
por: Bastid, Jérémy, et al.
Publicado: (2008)

Treatment of Crohn’s disease complicated with myelodysplastic syndrome via allogeneic hematopoietic stem cell transplantation: case report and literature review
por: Hu, Changmei, et al.
Publicado: (2014)

Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
por: Park, Joo Han, et al.
Publicado: (2014)

Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin?
por: Martins, Noel B., et al.
Publicado: (2017)

Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement
por: Sullivan, Keith M., et al.
Publicado: (2016)

P-027: SICKLE CELL DISEASE AND AUTOIMMUNE LIVER DISORDERS: SHOULD HEMATOPOIETIC STEM CELL TRANSPLANTATION BE DISCUSSED EARLY?
por: F., LACAILLE, et al.
Publicado: (2022)

Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?
por: Cerna, Karin, et al.
Publicado: (2023)

New Allogeneic Hematopoietic Stem Cell Transplantation Method: Hematopoietic Stem Cell Transplantation Plus Thymus Transplantation for Intractable Diseases
por: Hosaka, Naoki
Publicado: (2013)

Should We Consider Patients with Coexistent Hepatitis B or C Infection for Orthotopic Heart Transplantation?
por: Sekar, Baskar, et al.
Publicado: (2013)

What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?
por: Randolph, Brion V., et al.
Publicado: (2019)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

Infectious disease in hematopoietic stem cell transplantation
por: Sahu, Kamal Kant
Publicado: (2021)

A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation
por: Oliveira, Maria Carolina, et al.
Publicado: (2021)

Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease
por: Ruiz, Milton Artur, et al.
Publicado: (2017)

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Hengwei, et al.
Publicado: (2021)

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn’s Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD—Low Intensity Therapy Evaluation Study Investigators
por: Pockley, Alan Graham, et al.
Publicado: (2018)

Managing refractory Crohn’s disease: challenges and solutions
por: Tanida, Satoshi, et al.
Publicado: (2015)

Hematopoietic stem cell transplantation
por: Hatzimichael, Eleftheria, et al.
Publicado: (2010)

Hematopoietic Stem Cell Transplantation
por: Maedler-Kron, Chelsea, et al.
Publicado: (2016)

A179 AUTOLOGOUS BONE MARROW TRANSPLANT FOR REFRACTORY CROHN’S DISEASE: A CASE SERIES
por: Buttar, J, et al.
Publicado: (2022)

Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
por: Barcellini, Wilma, et al.
Publicado: (2019)

Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?
por: Konuma, Takaaki, et al.
Publicado: (2023)

Colovesical Fistula: Should It Be Considered a Single Disease?
por: Kiani, Qamar Hafeez, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5ehpnl1jjjcq0pi0266rlvigug